source:[1] Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 8-11 December 2025 - European Medicines Agency (https://www.ema.europa.eu/en/news/meeting-hig ...)[2] Golimumab biosimilar Gotenfia from STADA and Bio-Thera receives positive CHMP opinion - BioSpace (https://www.biospace.com/press-releases/golim ...)[3] CHMP decision levels the playing field for GSK's RSV jab - pharmaphorum (https://pharmaphorum.com/news/chmp-decision-l ...)